Diffuse Diabetic Macular Edema Clinical Trial
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.
Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe
dosage is identified that can be used in diffuse diabetic macular edema for treatment. in
this study, we are going to compare the effect of intra vitreal injection of Diclofenac and
Bevacizumab in primary treatment of diffuse diabetic macular edema.
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.
Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe
dosage is identified that can be used in diffuse diabetic macular edema for treatment. in
this study, we are going to compare the effect of intra vitreal injection of Diclofenac and
Bevacizumab in primary treatment of diffuse diabetic macular edema.
;
Intervention Model: Parallel Assignment, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00571142 -
Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema
|
Phase 3 | |
| Withdrawn |
NCT00567372 -
POSTERIOR SUB-TENON'S Avastin
|
Phase 4 | |
| Withdrawn |
NCT00600301 -
Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study
|
Phase 3 | |
| Completed |
NCT00886808 -
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
|
Phase 1 | |
| Recruiting |
NCT01218750 -
Triple Therapy for Diffuse Diabetic Macular Edema
|
N/A |